The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Utilization and predictors of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the Veterans Health Administration.
Gurdarshan Singh Sandhu
No relevant relationships to disclose
Suhong Luo
No relevant relationships to disclose
Angelique Zeringue
No relevant relationships to disclose
Kenneth Robert Carson
No relevant relationships to disclose
Kenneth Gerard Nepple
No relevant relationships to disclose
Seth A. Strope
No relevant relationships to disclose
M'Liss A. Hudson
No relevant relationships to disclose
Robert L. Grubb
No relevant relationships to disclose